Abstract
Objectives Our aim was to investigate the prevalence of apparent therapy-resistant hypertension (aTRH) in patients with clinical manifest cardiovascular disease (CVD), and to study clinical characteristics related to aTRH in this population. Setting The SMART (Second Manifestations of ARTerial disease) study is a large, single-centre cohort study in secondary care.
... read more